Recent Updates
Recently added Catalysts
ACHC Positive Sentiment

Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement

Key Takeaway: Acadia Healthcare Company has announced a proposed settlement regarding stockholder derivative litigation. This follows a preliminary approval order issued by the United States District Court for the Middle District of Tennessee. The case, identified as Lead Case No. 3:19-cv-00167, reflects ongoing legal proceedings involving the company.

Market Sentiment Analysis

POSITIVE FACTORS

  • Proposed settlement indicates progress in litigation.
  • Court's preliminary approval suggests a resolution is near.

Full Press Release Details

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, 2026 order providing preliminary approval issued by the United States District Court for the Middle District of Tennessee. UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF TENNESSEE NASHVILLE DIVISION IN RE ACADIA HEALTHCARE COMPANY, INC. STOCKHOLDER DERIVATIVE LITIGATION Lead Case No. 3:19-cv-00167

Frequently Asked Questions

What is the proposed settlement about?

The proposed settlement concerns stockholder derivative litigation involving Acadia Healthcare.

Which court issued the preliminary approval?

The preliminary approval was issued by the United States District Court for the Middle District of Tennessee.

What is the lead case number for this litigation?

The lead case number for the litigation is 3:19-cv-00167.

When was the preliminary approval order issued?

The preliminary approval order was issued on September 1, 2026.

Last updated: Sep 25, 2026